The World Economic Forum (WEF) calls for it, consumer goods technology businesses are investing in it in droves, and it’s ...

CISOs are under the gun to understand and address potential risks tied to geopolitical tensions, regulations and other ...

As medical costs in the United States continue to climb, health care providers face mounting pressure to deliver high-quality care while managing expenses. A groundbreaking study by researchers at the ...

The imaging giant is leasing warehouse space and contracting inventory management through a multiyear deal with logistics ...

As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

GSK, a British drugmaker, recently beat Q4 earnings estimates. The company is our FDI of the Month January 2025.

Prior to Dr. Reddy’s, Vin held senior leadership roles at Amneal Pharmaceuticals, G&W Laboratories, GlaxoSmithKline, UCB ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...